OT, but have you been following TROV? It has/is having quite a run on various news. I would appreciate any insights that you could offer. Many thanks.
Suntrust a highly regarded regional bank; its brokerage subsidiary, R-H, is likewise a well-respected, previously independent concern. The only thing that's noteworthy is their initiation of coverage. Doesn't make sense. Wild guess: a cancer patient connected to the Suntrust corporate family is in a clinical trial and has experienced exceptional results. Again, just a guess.
Makes sense; cash hoard invites such activity.
Depends. I will definitely accumulate additional shares. I think a buyout is likely before too long. It's just a great all around story. For me, there's more risk of being out of the stock than holding it. I don't have the luxury of babysitting it.
Everything's fine; nothing more than short-side price management. Much-a-do-about-nothing, really. Actually, such action only serves to corroborate the good-news narrative.
managing options expiration. Nothing more. Impact/Effect is yielding ever-diminishing returns. Becoming a yawnfest.